| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/22/2015 | WO2015009799A1 Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose |
| 01/22/2015 | WO2015009796A1 Composition for application to a mucosa comprising a methylcellulose |
| 01/22/2015 | WO2015009787A1 Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications |
| 01/22/2015 | WO2015009740A2 Anti-mucin 1 binding agents and uses thereof |
| 01/22/2015 | WO2015009035A1 Tissue-repairing injectable preparation comprising a polymer obtained by polymerising hydrophobic biocompatible macromolecule and hydrophilic biocompatible macromolecule |
| 01/22/2015 | WO2015008849A1 Self-emulsifying composition of ω-3 fatty acid |
| 01/22/2015 | WO2015008848A1 SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID |
| 01/22/2015 | WO2015008825A1 Orally disintegrating tablet |
| 01/22/2015 | WO2015008748A1 Soft capsule coating |
| 01/22/2015 | WO2015008399A1 Soft capsule coating |
| 01/22/2015 | WO2015008195A1 Pamam dendrimer derivatives for antithrombotic therapy |
| 01/22/2015 | WO2015008066A1 Cyclodextrin |
| 01/22/2015 | WO2015007912A1 Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drug |
| 01/22/2015 | WO2015007771A1 Polymer suitable for use in cell culture |
| 01/22/2015 | WO2015007760A1 Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| 01/22/2015 | WO2015007759A1 Etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| 01/22/2015 | US20150025511 Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| 01/22/2015 | US20150025480 Composition for the transdermal delivery of fentanyl |
| 01/22/2015 | US20150025243 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| 01/22/2015 | US20150025233 Use of lipid conjugates in the treatment of diseases |
| 01/22/2015 | US20150025228 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 01/22/2015 | US20150025227 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 01/22/2015 | US20150025196 Polyoxazoline polymers and methods for their preparation, conjugates of these polymers and medical uses thereof |
| 01/22/2015 | US20150025158 Novel thickening composition comprising pregelatinized waxy potato starch or pregelatinized cassava starch |
| 01/22/2015 | US20150025157 Novel sugar-derived gelator |
| 01/22/2015 | US20150025154 Ophthalmic composition |
| 01/22/2015 | US20150025149 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 01/22/2015 | US20150025148 Alditol free, storage stable thyroid hormone active drug formulations and methods for their production |
| 01/22/2015 | US20150025126 Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
| 01/22/2015 | US20150025112 Orally disintegrating tablet formulations of donepezil |
| 01/22/2015 | US20150025106 Thermogel formulation for combination drug delivery |
| 01/22/2015 | US20150025103 Oral liquid concentrate comprising brompheniramine, pseudoephedrine and dextromethorphan |
| 01/22/2015 | US20150025100 Formulations for parenteral delivery of compounds and uses thereof |
| 01/22/2015 | US20150025084 High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
| 01/22/2015 | US20150025082 Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| 01/22/2015 | US20150025060 Foamable Compositions and Kits Comprising One or More of a Channel Agent, a Cholinergic Agent, A nitric Oxide Donor and Related Agents and Their Uses |
| 01/22/2015 | US20150025051 Formulations for treating skin disorders |
| 01/22/2015 | US20150025050 Corticosteroids for the Treatment of Joint Pain |
| 01/22/2015 | US20150025043 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
| 01/22/2015 | US20150025029 Aptamer bioconjugate drug delivery device |
| 01/22/2015 | US20150025024 Solid Compositions |
| 01/22/2015 | US20150025023 Cyclodextrin |
| 01/22/2015 | US20150025020 Self-preserved oil dispersions comprising boric acid |
| 01/22/2015 | US20150025010 Novel albumin-free factor viii formulations |
| 01/22/2015 | US20150025005 Self-regulated peptide hydrogel for insulin delivery |
| 01/22/2015 | US20150024459 Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors |
| 01/22/2015 | US20150024458 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 01/22/2015 | US20150024455 Nucleophilic catalysts for oxime linkage |
| 01/22/2015 | US20150024206 Coated devices and methods for coating |
| 01/22/2015 | US20150024113 Cold-Water Soluble Extruded Starch Product |
| 01/22/2015 | US20150024066 Methods for preventing or treating excess weight using oxyntomodulin |
| 01/22/2015 | US20150024064 pKa Buffered Vitamin C Composition and Method |
| 01/22/2015 | US20150024059 Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes |
| 01/22/2015 | US20150024056 Controlled release sterile injectable aripiprazole formulation and method |
| 01/22/2015 | US20150024055 Enhanced immediate release formulations of topiramate |
| 01/22/2015 | US20150024054 Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/22/2015 | US20150024053 Topical wound treatment method and composition |
| 01/22/2015 | US20150024052 Nitric Oxide Releasing Pharmaceutical Compositions |
| 01/22/2015 | US20150024051 Injectable hydrogel system to modulate host response at bone implant interface |
| 01/22/2015 | US20150024047 Pharmaceutical composition and administrations thereof |
| 01/22/2015 | US20150024046 Abuse-proofed oral dosage form |
| 01/22/2015 | US20150024044 Gastric Reflux Resistant Dosage Forms |
| 01/22/2015 | US20150024043 Medi-Cap (Bio-Absorbable Capsules) |
| 01/22/2015 | US20150024037 Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making |
| 01/22/2015 | US20150024022 Hydrogel implants with varying degrees of crosslinking |
| 01/22/2015 | US20150024021 Method for treating a periodontal disease |
| 01/22/2015 | US20150024013 Capsule and powder formulations containing lanthanum compounds |
| 01/22/2015 | US20150024012 Article and methods for oral self-administration of nicotine |
| 01/22/2015 | US20150024001 Molecular mimic mucosal aids vaccine |
| 01/22/2015 | US20150023998 Stable Anthrax Vaccine Formulations |
| 01/22/2015 | US20150023995 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 01/22/2015 | US20150023989 New antibody drug conjugates (adcs) and the use thereof |
| 01/22/2015 | US20150023988 Potent and selective inhibitors of nav1.7 |
| 01/22/2015 | US20150023987 Immunogenic compositions and reagents for preparing |
| 01/22/2015 | US20150023974 Toll-like receptor 2 binding epitope and binding member thereto |
| 01/22/2015 | US20150023968 Compositions and methods for diagnosing and treating hyperthyroidism in companion animals |
| 01/22/2015 | US20150023965 Methods of treating urothelial carcinoma |
| 01/22/2015 | US20150023963 Method for the production of variable domains |
| 01/22/2015 | US20150023946 Combined Use of a Sulfated Glycosaminoglycan and a Hyaluronidase for Improving the Bioavailability of Factor VIII |
| 01/22/2015 | US20150023929 Oral unit dosage forms and uses of same for the treatment of gaucher disease |
| 01/22/2015 | US20150023912 Combinations of albumin-based drug delivery systems |
| 01/22/2015 | US20150023888 Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine |
| 01/22/2015 | US20150023880 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 01/22/2015 | US20150023875 System for Targeted Delivery of Therapeutic Agents |
| 01/22/2015 | US20150023874 Folate receptor alpha binding ligands |
| 01/22/2015 | US20150023872 Homing agents |
| 01/22/2015 | US20150023871 Compositions and methods for the diagnosis and treatment of tumor |
| 01/22/2015 | US20150023870 Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases |
| 01/22/2015 | US20150020798 Inhaler |
| 01/21/2015 | EP2826493A1 Polymer suitable for use in cell culture |
| 01/21/2015 | EP2826492A1 Drug delivery conjugate capable of controlled release, and use thereof |
| 01/21/2015 | EP2826477A1 Solid composition of amino carboxylate salt |
| 01/21/2015 | EP2825582A1 Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline |
| 01/21/2015 | EP2825565A1 Glycogen-based cationic polymers |
| 01/21/2015 | EP2825563A1 Process for the preparation of polysaccharide nanoparticles |
| 01/21/2015 | EP2825207A1 Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
| 01/21/2015 | EP2825206A1 Controlled release formulations for the delivery of hif-1 inhibitors |
| 01/21/2015 | EP2825205A1 Polymeric conjugates of c1-inhibitors |
| 01/21/2015 | EP2825204A1 Polymeric conjugates of c-1 inhibitors |
| 01/21/2015 | EP2825203A1 Glycosaminoglycan and synthetic polymer materials for blood-contacting applications |